NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 356 filers reported holding NEKTAR THERAPEUTICS in Q1 2019. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $964,806,000 | +186.0% | 44,698 | +141.3% | 0.01% | +125.0% |
| Q3 2019 | $337,396,000 | -47.4% | 18,523 | +2.7% | 0.00% | -42.9% |
| Q2 2019 | $641,899,000 | +9.6% | 18,041 | +3.5% | 0.01% | 0.0% |
| Q1 2019 | $585,413,000 | -11.2% | 17,423 | -13.1% | 0.01% | -22.2% |
| Q4 2018 | $659,109,000 | -46.2% | 20,052 | -0.3% | 0.01% | -35.7% |
| Q3 2018 | $1,225,845,000 | +55.0% | 20,109 | +24.1% | 0.01% | +55.6% |
| Q2 2018 | $791,046,000 | – | 16,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |